ADCs
How Lessons from Breast Cancer Are Shaping ADC Development Across Solid Tumors
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-05Oct 8, 2026
Heme-Onc
Therapeutic and Diagnostic Advances Benefiting Patients with Hematologic Malignancies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-09-26-PA-20Sep 28, 2026
Heme-Onc
The Next Generation of Targeted Therapies in Hematologic Malignancies
PAO-09-26-PA-11Sep 24, 2026
Oncolytic Viruses
Turning Oncolytic Viruses into Manufacturable Cancer Therapies
Luisa Amoedo Otero
Recipharm Advanced Bio
PAO-09-26-CL-04Sep 22, 2026
Oncolytic Viruses
Manufacturing Oncolytic Viruses: Where Complexity Demands Experience
Mathias Kahl
IDT Biologika
PAO-09-26-CL-01Sep 17, 2026
MRD
Measurable Residual Disease Moves Deeper Into Hematologic Cancer Development
Pharma's Almanac
PAO-09-26-PA-13Sep 17, 2026
BsAbs in Oncology
Bispecific Antibodies Move Into the Heme-Onc Mainstream
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-12Sep 16, 2026
Pediatric Oncology
Why Pediatric Oncology Needs Its Own Drug Development Paradigm
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-04Sep 4, 2026
Masked Antibody
Expanding the Oncology Therapeutic Window Through Masked Antibody Technology
Sean McCarthy, Ph.D; David Alvaro, Ph.D.
CytomX Therapeutics
PAO-08-26-CL-09Aug 14, 2026
Vaccine Development
New Vaccine Technologies Expand the Frontiers of Prevention and Treatment
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-11Aug 14, 2026
Vaccines
Beyond Infectious Disease: Vaccines for Cancer and Chronic Conditions
Pharma's Almanac
PAO-08-26-PA-08Aug 12, 2026
LAIs
Seven Biotechs Developing Long-Acting Injectable Drugs
Vedangi Joshi
Nice Insight
PAO-08-26-PA-10Aug 10, 2026
In Vivo CAR-T
Five Companies Bringing In Vivo CAR-T Therapy Closer to the Clinic
Emma Gormlie
Nice Insight
PAO-07-26-PA-13Jul 30, 2026
Oncology
Harnessing Macrophage Biology to Overcome Tumor Immune Evasion
Roy Maute, Ph.D.; David Alvaro, Ph.D.
Pheast Therapeutics
PAO-07-26-CL-03Jul 23, 2026
Rare Cancer CGT
Developing Cell and Gene Therapies for Rare Oncology Applications
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-10Jul 16, 2026
Tumor-Agnostic
Moving Beyond Tumor Origin: The Rise of Tissue-Agnostic Oncology
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-05Jul 8, 2026
Basket Trials
Basket Trials and the Future of Rare Cancer Research
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-02Jul 2, 2026
Organoids
Data-Centric Organoid Services for Predictive Drug Response and Next-Generation Oncology Research
Seahee Kim, Ph.D.
Samsung Biologics
PAO-06-26-CL-04Jul 1, 2026
Research Collab
10x Genomics and Cleveland Clinic Collaborate in Diagnostic Applications of Single Cell and Spatial Technologies in Bladder Cancer
10x Genomics
PR-06-26-02Jun 17, 2026
Ovarian Cancer
Oncolytic Viruses at a Turning Point: Advancing Olvi-Vec for Advanced Ovarian Cancer
David Alvaro, Ph.D.; Jason Litten, M.D.
Pharma's Almanac
PAO-04-26-CL-03Apr 21, 2026